Alan B. Bergman
Chief Financial OfficerMr. Alan B. Bergman is Chief Financial Officer of 20/20 Biolabs, Inc. from February 17, 2026 and served as its Interim Chief Financial Officer since December 2025 until February 17, 2026. Mr. Bergman served as Chief Financial Officer at Plethy Inc. from December 2024 to December 2025. He served as Chief Financial Officer of Smart for Life, Inc. (formerly known as Bonne Santé Group, Inc.) since January 2021. Mr. Bergman served as the Chief Financial Officer of Bright Mountain Media, Inc. since June 24, 2019 until September 01, 2020 and served as its Vice President of Finance since September 01, 2020 until December 31, 2020. He also served as Vice President Finance of Greenlane Holdings, Inc. from December 2018 to May 2019. From February 2018 until December 2018 he served as Controller for Boston Proper LLC, a women’s online and catalog retailer, where he oversaw the finance and accounting department. From October 2013 until February 2018 Mr. Bergman served as Controller for Woodfield Distribution, LLC, known as WDSrx from October 2013 to February 2018. From May 2011 until March 2013 he served as Vice President of Finance for Latitude Solutions, Inc. From 2009 until 2011 Mr. Bergman was an Audit Manager with Mallah Furman & Co., a PCAOB-registered accounting firm which was acquired by EisnerAmper LLP in 2015, where he planned, performed and supervised financial statement audits in accordance with GAAP, GAAS and the Sarbanes Oxley Act of 2002. From 2005 until 2009 he was a Senior Auditor with Weinberg & Company, P.A., a PCAOB-registered accounting firm, where he planned and performed financial statement audits in accordance with GAAP, GAAS and the Sarbanes Oxley Act of 2002. Mr. Bergman began his accounting career in 2000 with Deloitte & Touche LLP, a national accounting firm, serving as a Staff Associate until 2002 and a Senior Associate from 2002 until 2005. Since 2004 Mr. Bergman, a certified public accountant, has served as an Adjunct Professor at Florida Atlantic University and Millennia Atlantic University, teaching courses in Accounting Theory I, II and III, Managerial Accounting, Advanced Accounting Information Systems and Accounting Capstone. From 2003 to 2005 he was also a facilitator for Deloitte & Touche LLP’s national and local training seminars. Mr. Bergman received a B.S. in Finance from the University of Tampa and a Master of Accounting from the University of Miami.
Positions
- Company Name20/20 Biolabs, Inc.Stock CodeAIDXPositionChief Financial OfficerColleagues
- JCJonathan CohenFounder, CEO, President & Director
- JGJohn G. ComptonIndependent Chairman
- JZJiming ZhouChief Operating Officer
- MSMichael Saul LebowitzChief Scientific Officer
- DLDavid LeesDirector of Sales
- MAMichael A. RossIndependent Director
- RMRichard M. CohenIndependent Director
- PRPrasanth ReddyIndependent Director
